We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 27 MARCH 2014
Successful Use Of Inter Partes Review To Cancel Claims Asserted In Parallel Litigation
Duane Morris LLP
Contributor
Duane Morris LLP
View firm profileIn a trio of March 6, 2014 inter partes review (IPR) decisions, the Patent Trial and Appeal Board (PTAB) canceled patent claims related to next generation DNA sequencing technology, after Illumina, Inc. countered Columbia University’s patent infringement suit by successfully petitioning for IPR of claims in three of five of Columbia’s patents-in-suit.
United StatesIntellectual Property










